Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma.
Ikeda K, Osaki Y, Nakanishi H, Nasu A, Kawamura Y, Jyoko K, Sano T, Sunagozaka H, Uchino K, Minami Y, Saito Y, Nagai K, Inokuchi R, Kokubu S, Kudo M. Ikeda K, et al. Among authors: nakanishi h. Oncology. 2014;87 Suppl 1:73-7. doi: 10.1159/000368148. Epub 2014 Nov 22. Oncology. 2014. PMID: 25427736 Review.
Early decrease in α-fetoprotein, but not des-γ-carboxy prothrombin, predicts sorafenib efficacy in patients with advanced hepatocellular carcinoma.
Kuzuya T, Asahina Y, Tsuchiya K, Tanaka K, Suzuki Y, Hoshioka T, Tamaki S, Kato T, Yasui Y, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Izumi N. Kuzuya T, et al. Among authors: nakanishi h. Oncology. 2011;81(3-4):251-8. doi: 10.1159/000334454. Epub 2011 Nov 23. Oncology. 2011. PMID: 22116493
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.
Hosokawa T, Kurosaki M, Tsuchiya K, Matsuda S, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Nakata T, Nishimura T, Suzuki S, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Izumi N. Hosokawa T, et al. Among authors: nakanishi h. World J Gastroenterol. 2013 Jan 14;19(2):249-57. doi: 10.3748/wjg.v19.i2.249. World J Gastroenterol. 2013. PMID: 23345948 Free PMC article.
Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study.
Yasui Y, Kudo A, Kurosaki M, Matsuda S, Muraoka M, Tamaki N, Suzuki S, Hosokawa T, Ueda K, Matsunaga K, Nakanishi H, Tsuchiya K, Itakura J, Takahashi Y, Tanaka S, Asahina Y, Enomoto N, Arii S, Izumi N. Yasui Y, et al. Among authors: nakanishi h. Oncology. 2014;86(1):53-62. doi: 10.1159/000356643. Epub 2014 Jan 8. Oncology. 2014. PMID: 24401597
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Takada H, Tsuchiya K, Yasui Y, Nakakuki N, Tamaki N, Suzuki S, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Izumi N. Takada H, et al. Among authors: nakanishi h. Cancer Med. 2016 Nov;5(11):3111-3120. doi: 10.1002/cam4.932. Epub 2016 Oct 17. Cancer Med. 2016. PMID: 27748052 Free PMC article.
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy.
Takaura K, Kurosaki M, Inada K, Kirino S, Yamashita K, Muto T, Osawa L, Sekiguchi S, Hayakawa Y, Higuchi M, Kaneko S, Maeyashiki C, Tamaki N, Yasui Y, Itakura J, Tsuchiya K, Nakanishi H, Takahashi Y, Izumi N. Takaura K, et al. Among authors: nakanishi h. PLoS One. 2022 Feb 23;17(2):e0264075. doi: 10.1371/journal.pone.0264075. eCollection 2022. PLoS One. 2022. PMID: 35196341 Free PMC article.
2,070 results